Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx Holdings plc (MGTX) PT Raised to 'Street High' $55 at Chardan Capital Markets
-
MeiraGTx Holdings plc (MGTX) Prices 5M Share Offering at $12.85/Sh
-
MeiraGTx (MGTX) Announces Pricing of Public Offering of 5M Ordinary Shares at $12.85/sh
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Holdings plc (MGTX) Announces Proposed 5M Share Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
MeiraGTx to Present at Upcoming Scientific and Investor Conferences
-
MeiraGTx to Present at Upcoming Scientific and Investor Conferences
-
MeiraGTx Holdings plc (MGTX) PT Raised to $45 at Chardan Capital Markets
-
MeiraGTx Holdings plc (MGTX) Prices 3.2M Share Common Offering at $23.50/Sh
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Holdings plc (MGTX) Announces Proposed $75M Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
MeiraGTx Holdings plc (MGTX) PT Raised to $40 at Chardan Capital Markets; 3rd Investment by J&J
-
MeiraGTx Holdings plc (MGTX) Reports $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
MeiraGTx to Present at Upcoming Conferences
-
MeiraGTx to Present at Upcoming Conferences
-
Chardan Capital Markets Starts MeiraGTx Holdings plc (MGTX) at Buy
-
MeiraGTx Announces Closing of Initial Public Offering
-
MeiraGTx Announces Closing of Initial Public Offering
-
MeiraGTx Holdings plc (MGTX) IPO Opens Flat
